Cancer risk of hypertensive patients taking calcium antagonists

Journal of Hypertension

Volumn 16, Issue 1, 1998, Pages 119-124

  Hole, David J ^a   Gillis, Charles R ^a   McCallum, Iain R ^b   McInnes, Gordon T ^c   MacKinnon, Pauline L ^a   Meredith, Peter A ^c   Murray, Lilian S ^c   Robertson, James W K ^b   Lever, Anthony F ^c,d  

^a RUCHILL HOSPITAL   (United Kingdom)

^b CSC Computer Sciences Ltd   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d WESTERN INFIRMARY   (United Kingdom)

Author keywords

Calcium antagonists; Calcium channel blockers; Cancer incidence; Cancer mortality

Indexed keywords

ANTIHYPERTENSIVE AGENT; CALCIUM ANTAGONIST;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER RISK; CAUSE OF DEATH; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0031915212     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199816010-00017     Document Type: Article

References (14)

1. Pahor M, Guralnik JM, Salive ME, Corti M-C, Carbonin P, Havlik RJ. Do calcium channel blockers increase the risk of cancer? Am J Hypertens 1996, 9:695-699.
2. Pahor M, Guralnik JM, Ferrucci L, Corti, M-C, Salive ME, Cerhan JR, et al. Calcium-channel blockade and incidence of cancer in aged populations. Lancet 1996, 348:493-497.
3. Jick H, Jick S, Derby LE, Vasilakis C, Meyers MW, Meier CR. Calcium-channel blockers and risk of cancer. Lancet 1997, 349:525-528.
4. Olsen JH, Sorensen HT, Friis S, McLaughlin JK, Steffensen FH, Nielsen GL. Cancer risk in users of calcium channel blockers. Hypertension 1997, 29:1091-1094.
5. Hole DJ, Hawthorne VM, Isles CG, McGhee SM, Robertson JWK, Gillis CR, et al. Incidence of and mortality from cancer in hypertensive patients. BMJ 1993, 306:609-611.
6. Gillis CR, Hole DJ, Lamont D, Boyle P, Graham A. Cancer incidence in the West of Scotland. In Cancer Incidence in Five Continents. Vol V. Edited by Muir C, Waterhouse J, Mack T, Powell J, Whelan S. Lyons: International Association for Research on Cancer; 1987:704-707.
7. Isles CG, Walker LM, Beevers DG, Brown I, Cameron HL, Clarke J, et al. Mortality in patients of the Glasgow Blood Pressure Clinic. J Hypertens 1986, 4:141-156.
8. Bonferroni Correction. In: Practical Statistics for Medical Research. Edited by Altman D. London: Chapman & Hall; 1991:210-212.
9. McInnes GT, McGhee SM. Delivery of care for hypertension. J Hum Hypertens 1995, 9:429-433.
10. Ad Hoc Subcommittee of the Liaison Committee of the World Health Organization and the International Society of Hypertension. Effect of calcium antagonists and risk of coronary heart disease, cancer and bleeding. J Hypertens 1997, 18:105-115.
11. Hamet P. Cancer and hypertension: an unresolved issue. Hypertension 1996, 28:321-324.
12. Dyer AR, Stamler J, Berkson DM, Lindberg HA, Stevens E. High blood pressure: a risk factor for cancer mortality? Lancet 1975, i:1051-1056.
13. Wannamethee G, Shaper AG. Blood pressure and cancer in middle-aged British men. Int J Epidemiol 1996, 25:22-31.
14. Chow W-H, McLaughlin JK, Mandel JS, Wacholder S, Niwa S, Fraument JF Jr. Risk of renal cell cancer in relation to diuretics, antihypertensive drugs and hypertension. Cancer Epidemiol Biomarkers Prev 1995, 4:327-331.